Patent 7037919 was granted and assigned to Kaken Pharmaceutical on May, 2006 by the United States Patent and Trademark Office.
Tetrahydroquinoline derivatives of general formula (I) or salts thereof, having a specific and strong binding affinity for AR and exhibiting AR agonism or antagonism; and pharmaceutical compositions containing the derivatives or the salts.